AniTech Limited is a preclinical contract research organisation (CRO), which offers a full range of in vivo and in vitro testing services and regulatory documentation support for the safety assessment of pharmaceuticals, medical devices and supplementary health products. We customise preclinical studies according to our clients’ requirements to ensure that drug efficacy and safety assessments are conducted efficiently to save time and cost. We leverage EEG technology with an artificial intelligence (AI) and machine learning (ML) platform to perform high-throughput pharmaco-EEG studies to screen drugs. We offer an integrated approach of combined AI and conventional preclinical studies to facilitate the drug-screening processs as mandated by the US Food and Drug Administration (FDA, USA) and China’s National Medical Products Administration (NMPA, China). Our validated and optimised screening platform has high clinical predictivity, which saves time and reduces cost for the development of investigational new drugs (INDs).